{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:14:17Z","timestamp":1792088057578,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011808.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000}}],"reference-count":48,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011808.pub3","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T15:07:11Z","timestamp":1657292831000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhaled nitric oxide for treating pain crises in people with sickle cell disease"],"prefix":"10.1002","volume":"2022","author":[{"given":"Tarek","family":"Aboursheid","sequence":"additional","affiliation":[{"name":"Internal Medicine; Hamad Medical Corporation; Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Albaroudi","sequence":"additional","affiliation":[{"name":"Emergency Department; Hamad Medical Corporation; Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fares","family":"Alahdab","sequence":"additional","affiliation":[{"name":"Evidence-based Practice Center; Mayo Clinic; Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD011808.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2011.235","article-title":"Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial","volume":"305","author":"Gladwin","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD011808.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ajh.21832","article-title":"Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis","volume":"85","author":"Head","year":"2010","journal-title":"American Journal of Hematology"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD011808.pub3-BIB0003|cit3","first-page":"11a","article-title":"Inhaled nitric oxide for treatment of acute vaso-occlusive crisis in sickle cell disease","volume":"100","author":"Weiner","year":"2002","journal-title":"Blood"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD011808.pub3-BIB0004|cit4","first-page":"86A","article-title":"Effectiveness and safety of inhaled nitric oxide for the treatment of vaso-occlusive crisis in pediatric sickle cell disease","volume":"51","author":"Weiner","year":"2002","journal-title":"Pediatric Research"},{"issue":"9","key":"10.1002\/14651858.CD011808.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.289.9.1136","article-title":"Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease","volume":"289","author":"Weiner","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD011808.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.CIR.0000044943.12533.A8","article-title":"Divergent nitric oxide bioavailability in men and women with sickle cell disease","volume":"107","author":"Gladwin","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0007|cit7","unstructured":"Jison ML Hunter L Coles W Nichols J Gladwin MT Acute vasodilator responsiveness in secondary pulmonary hypertension of sickle cell disease American Thoracic Society International Conference; 2004 May 21-26; Orlando, FL 2004 A56"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0008|cit8","unstructured":"Jison ML Kato GJ Machado R Hunter L Coles W Nichols J Acute vasodilator responsiveness in secondary pulmonary hypertension of sickle cell disease 27th Annual Meeting of the National Sickle Cell Disease Program; 2004 April 18-21; Los Angeles 2004 40"},{"issue":"Meeting abstrac","key":"10.1002\/14651858.CD011808.pub3-BIB0009|cit9","first-page":"Abstract no: A6","article-title":"Inhaled nitric oxide in the treatment of acute chest syndrome in adult sickle cell patients: a randomised, double-blind, placebo-controlled trial","volume":"189","author":"Maitre","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0010|cit10","unstructured":"Inhaled nitric oxide for pediatric painful sickle crisis clinicaltrials.gov\/show\/NCT00142051"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0011|cit11","unstructured":"Nitric oxide therapy for acute chest syndrome in sickle cell disease children clinicaltrials.gov\/show\/NCT01089439"},{"issue":"3","key":"10.1002\/14651858.CD011808.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/S2352-3026(14)00020-9","article-title":"Nitric oxide-based treatment for sickle cell leg ulcers?","volume":"1","author":"Steinberg","year":"2014","journal-title":"Lancet Haematology"},{"issue":"8","key":"10.1002\/14651858.CD011808.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1073\/pnas.74.8.3203","article-title":"Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations","volume":"74","author":"Arnold","year":"1977","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/asheducation-2007.1.97","article-title":"Current issues in sickle cell pain and its management","volume":"1","author":"Ballas","year":"2007","journal-title":"Hematology. American Society of Hematology Education Program"},{"issue":"6","key":"10.1002\/14651858.CD011808.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2715\u201325","DOI":"10.1152\/ajpheart.00986.2004","article-title":"Critical role of endothelial cell activation in hypoxia induced vaso-occlusion in transgenic sickle mice","volume":"288","author":"Belcher","year":"2005","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"7108","key":"10.1002\/14651858.CD011808.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD011808.pub3-BIB0017|cit17","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/135581960000500105","article-title":"Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action)","volume":"5","author":"Campbell","year":"2005","journal-title":"Journal of Health Services Research and Policy"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0019|cit19","unstructured":"Covidence Veritas Health Innovation"},{"issue":"3","key":"10.1002\/14651858.CD011808.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/cc7734","article-title":"Bench-to-bedside review: inhaled nitric oxide therapy in adults","volume":"13","author":"Creagh-Brown","year":"2009","journal-title":"Critical Care"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0021|cit21","unstructured":"Deeks JJ Higgins JPT Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011808.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0025|cit25","unstructured":"Approval of nitric oxide for inhalation (updated 2010) www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/020845s011lbl.pdf"},{"issue":"5","key":"10.1002\/14651858.CD011808.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1164\/ajrccm.159.5.9810094","article-title":"The acute chest syndrome in sickle cell disease possible role of nitric oxide in its pathophysiology and treatment","volume":"159","author":"Gladwin","year":"1999","journal-title":"American Journal of Respiratory Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011808.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0037-1963(01)90027-7","article-title":"Nitric oxide therapy in sickle cell disease","volume":"38","author":"Gladwin","year":"2001","journal-title":"Seminars in Hematology"},{"issue":"9","key":"10.1002\/14651858.CD011808.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011808.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD011808.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0031|cit31","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0032|cit32","unstructured":"Higgins JP Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0033|cit33","unstructured":"Higgins JP Altman DG Sterne JA on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0034|cit34","unstructured":"Higgins JP Deeks JJ Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0035|cit35","volume-title":"Classification of Chronic Pain","author":"IASP Task Force on Taxonomy","year":"2004"},{"issue":"4","key":"10.1002\/14651858.CD011808.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jpainsymman.2004.07.006","article-title":"Are there phases to the vaso-occlusive painful episode in sickle cell disease?","volume":"29","author":"Jacob","year":"2005","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<15::AID-AJH3>3.0.CO;2-P","article-title":"Sequential nitric oxide measurements during the emergency department treatment of acute vaso-occlusive sickle cell crisis","volume":"64","author":"Lopez","year":"2000","journal-title":"American Journal of Hematology"},{"issue":"6","key":"10.1002\/14651858.CD011808.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00043426-200011000-00009","article-title":"Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome","volume":"22","author":"Morris","year":"2000","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0039|cit39","first-page":"111","article-title":"Role of cyclic-GMP in relaxations of vascular smooth muscle","volume":"7 Suppl 3","author":"Murad","year":"1985","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"e4063","DOI":"10.1136\/bmj.e4063","article-title":"Management of an acute painful sickle cell episode in hospital: summary of NICE guidance","volume":"344","author":"Gillis","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0041|cit41","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"issue":"13","key":"10.1002\/14651858.CD011808.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD011808.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0044|cit44","unstructured":"Sterne JAC Egger M Moher D on behalf of the Cochrane Bias Methods Group Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"1","key":"10.1002\/14651858.CD011808.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0027-9684(15)30471-5","article-title":"Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease","volume":"102","author":"Wilkie","year":"2010","journal-title":"Journal of the National Medical Association"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"137, Abstract n","DOI":"10.1016\/j.schres.2007.12.319","article-title":"The Leeds Outcomes Stakeholders Survey (LOSS) Study","volume":"98 Suppl","author":"Xia","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD011808.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"S536\u201341","DOI":"10.1016\/j.amepre.2010.01.001","article-title":"Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007","volume":"38","author":"Yusuf","year":"2010","journal-title":"American Journal of Preventive Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011808.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cpem.2010.09.002","article-title":"Evaluation and treatment of sickle cell pain in the emergency department: paths to a better future","volume":"1","author":"Zempsky","year":"2010","journal-title":"Clinical Pediatric Emergency Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:24:18Z","timestamp":1716423858000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011808.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011808.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]}}}